Evidence map›Paper›PMID 37804999›Full record

ArticleDiabetes research and clinical practice2023

Trends in all-cause mortality among adults with diagnosed type 2 diabetes in West Malaysia: 2010 - 2019.

Lee-Ling Lim, Alia Abdul Aziz, Helen Dakin, John Buckell, Yuan-Liang Woon, Laurence Roope, Arunah Chandran, Feisul I Mustapha, Edward W Gregg, Philip M Clarke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes research and clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lee-Ling LimDepartment of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Asia Diabetes Foundation, Hong Kong SAR, China. Electronic address: leeling.lim@ummc.edu.my.
Alia Abdul AzizDepartment of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Helen DakinHealth Economics Research Centre, Nuffield Department of Public Health, University of Oxford, Oxford, United Kingdom.
John BuckellHealth Economics Research Centre, Nuffield Department of Public Health, University of Oxford, Oxford, United Kingdom.
Yuan-Liang WoonCentre for Clinical Epidemiology, Institute for Clinical Research, National Institute of Health, Selangor, Malaysia.
Laurence RoopeHealth Economics Research Centre, Nuffield Department of Public Health, University of Oxford, Oxford, United Kingdom.
Arunah ChandranNon-communicable Disease Section, Disease Control Division, Ministry of Health, Putrajaya, Malaysia.
Feisul I MustaphaNon-communicable Disease Section, Disease Control Division, Ministry of Health, Putrajaya, Malaysia.
Edward W GreggDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Philip M ClarkeHealth Economics Research Centre, Nuffield Department of Public Health, University of Oxford, Oxford, United Kingdom. Electronic address: philip.clarke@ndph.ox.ac.uk.

Funding

Medical Research Council MR/T018593/1
6 · The paper itself

Abstract

aimsWe determined 10-year all-cause mortality trends in diagnosed type 2 diabetes (T2D) population in West Malaysia, a middle-income country in the Western-Pacific region.

methodsOne million T2D people aged 40-79 registered in the National Diabetes Registry (2009-2018) were linked to death records (censored on 31 December 2019). Standardized absolute mortality rates and standardized mortality ratios (SMRs) were estimated relative to the Malaysian general population, and standardized to the 2019 registry population with respect to sex, age group, and disease duration.

resultsOverall all-cause standardized mortality rates were unchanged in both sexes. Rates increased in males aged 40-49 (annual average percent change [AAPC]: 2.46 % [95 % CI 0.42 %, 4.55 %]) and 50-59 (AAPC: 1.91 % [95 % CI 0.73 %, 3.10 %]), and females aged 40-49 (AAPC: 3.39 % [95 % CI 1.32 %, 5.50 %]). In both sexes, rates increased among those with 1) > 15 years disease duration, 2) prior cardiovascular disease, and 3) Bumiputera (Malay/native) ethnicity. The overall SMR was 1.83 (95 % CI 1.80, 1.86) for males and 1.85 (95 % CI 1.82, 1.89) for females, being higher in younger age groups and showed an increasing trend in those with either > 15 years disease duration or prior cardiovascular disease.

conclusionsMortality trends worsened in certain T2D population in Malaysia.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2AdultAgedAsian PeopleFemaleHumansMalaysiaMaleMiddle AgedMortalityRegistriesCardiovascular diseaseDiabetes mellitusEpidemiologyEthnicityHealth disparityMiddle-income country

Identifiers

PMID37804999
PMCPMC10701628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.